Your browser doesn't support javascript.
loading
School-Based Serosurveys to Assess the Validity of Using Routine Health Facility Data to Target Malaria Interventions in the Central Highlands of Madagascar.
Steinhardt, Laura C; Ravaoarisoa, Elisabeth; Wiegand, Ryan; Harimanana, Aina; Hedje, Judith; Cotte, Annett H; Zigirumugabe, Sixte; Kesteman, Thomas; Rasoloharimanana, Tsikiniaina L; Rakotomalala, Emma; Randriamoramanana, Anny M; Rakotondramanga, Jean-Marius; Razanatsiorimalala, Seheno; Mercereau-Puijalon, Odile; Perraut, Ronald; Ratsimbasoa, Arsène; Butts, Jessica; Rogier, Christophe; Piola, Patrice; Randrianarivelojosia, Milijaona; Vigan-Womas, Inès.
Affiliation
  • Steinhardt LC; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Ravaoarisoa E; Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Wiegand R; Faculty of Sciences, University of Antananarivo, Antananarivo, Madagascar.
  • Harimanana A; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hedje J; Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Cotte AH; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Zigirumugabe S; US President's Malaria Initiative, Antananarivo, Madagascar.
  • Kesteman T; Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rasoloharimanana TL; U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rakotomalala E; US President's Malaria Initiative, Antananarivo, Madagascar.
  • Randriamoramanana AM; United States Agency for International Development, Washington, District of Columbia, USA.
  • Rakotondramanga JM; Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Razanatsiorimalala S; Fondation Merieux, Lyon, France.
  • Mercereau-Puijalon O; Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Perraut R; Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Ratsimbasoa A; Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Butts J; Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Rogier C; Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Piola P; Parasites and Insect Vectors Department, Institut Pasteur, Paris, France.
  • Randrianarivelojosia M; Immunology Unit, Institut Pasteur de Dakar, Dakar, Senegal.
  • Vigan-Womas I; National Malaria Control Program of Madagascar, Ministry of Public Health, Antananarivo, Madagascar.
J Infect Dis ; 223(6): 995-1004, 2021 03 29.
Article in En | MEDLINE | ID: mdl-32761176
ABSTRACT

BACKGROUND:

In low-malaria-transmission areas of Madagascar, annual parasite incidence (API) from routine data has been used to target indoor residual spraying at subdistrict commune level. To assess validity of this approach, we conducted school-based serological surveys and health facility (HF) data quality assessments in 7 districts to compare API to gold-standard commune-level serological measures.

METHODS:

At 2 primary schools in each of 93 communes, 60 students were randomly selected with parents and teachers. Capillary blood was drawn for rapid diagnostic tests (RDTs) and serology. Multiplex bead-based immunoassays to detect antibodies to 5 Plasmodium falciparum antigens were conducted, and finite mixture models used to characterize seronegative and seropositive populations. Reversible catalytic models generated commune-level annual seroconversion rates (SCRs). HF register data were abstracted to assess completeness and accuracy.

RESULTS:

RDT positivity from 12 770 samples was 0.5%. Seroprevalence to tested antigens ranged from 17.9% (MSP-1) to 59.7% (PF13). Median commune-level SCR was 0.0108 (range, 0.001-0.075). Compared to SCRs, API identified 71% (95% confidence interval, 51%-87%) of the 30% highest-transmission communes; sensitivity declined at lower levels. Routine data accuracy did not substantially affect API performance.

CONCLUSIONS:

API performs reasonably well at identifying higher-transmission communes but sensitivity declined at lower transmission levels.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2021 Document type: Article Affiliation country: Estados Unidos Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: J Infect Dis Year: 2021 Document type: Article Affiliation country: Estados Unidos Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA